CompletedPhase 2

A Study to Compare Oxybutynin to a Placebo in Women and the Effect on Plantar Hyperhidrosis

32 participantsStarted 2010-03

Plain-language summary

A study in which the experimental treatment procedure is compared to a standard (control) treatment, The use of oxybutynin in the late postoperative thoracic sympathectomy for women: 1. To Evaluate the effect of oxybutynin on plantar hyperhidrosis. 2. To evaluate the effect of oxybutynin in compensatory hyperhidrosis. 3. To compare the results of questionnaires on quality of life and specific for hyperhidrosis to the results of TEWL.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * women with persistent plantar hyperhidrosis with limitation to their usual activities. Exclusion Criteria: * pregnancy, * breastfeeding, * glaucoma, * use of tricyclic medications, * prior use of anticholinergic * side effects exacerbated, such as diarrhea, gastritis, constipation or dry mouth.

What they're measuring

To evaluate the effect of oxybutynin in plantar hyperhidrosis

Timeframe: 60 days

Trial details

NCT IDNCT01328015

SponsorFederal University of São Paulo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-05

View on ClinicalTrials.gov More Hyperhidrosis trials